Patents for C12R 1 - Micro-organisms (92,025) |
---|
12/31/1996 | US5589582 Polynucleotides en coding porcine cytokines |
12/31/1996 | US5589581 DNA sequences useful for the synthesis of carotenoids |
12/31/1996 | US5589574 Assay for bone alkaline phosphatase |
12/31/1996 | US5589573 Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and DNA base sequences encoding those sequences |
12/31/1996 | US5589386 Hydrolysis of cholinesterase inhibitors using parathion hydrolase |
12/31/1996 | US5589384 Formation of pentamer complex and binding to gangliosides and hinges of glycineproline and antigens or epitopes |
12/31/1996 | US5589383 Protease deletion |
12/31/1996 | US5589380 Isolated DNA molecule encoding SHET1 of Shigella flexneri 2a and mutant Shigella flexneri 2a |
12/31/1996 | US5589377 Cells and genetic engineering |
12/31/1996 | US5589371 Polypeptides and yeast expression vectors for culture |
12/31/1996 | US5589366 Process for producing antiparasitic macrolide antibiotics |
12/31/1996 | US5589358 Ileal bile acid transporter compositions and methods |
12/31/1996 | US5589355 Process for producing riboflavin |
12/31/1996 | US5589354 Halogenation of cephalexin with haloperoxidase from Rathayibacter biopuresis |
12/31/1996 | US5589345 Leukemia cells |
12/31/1996 | US5589343 Antibodies which bind to molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes |
12/31/1996 | US5589338 Nucleic acids encoding a mutant form of human serum albumin involved in familial dysalbuminemic hyperthyroxinemia |
12/31/1996 | US5589168 Strain of enterococcus useful for treatment and prevention of irritable bowel syndrome |
12/31/1996 | US5589047 Using dielectrophoresis for genetic engineering |
12/31/1996 | CA2180280A1 Adenyl-cyclase-hemolysin (ac-hly)-protecting epitopes; use thereof for the treatment or the prevention of infections by bordetella |
12/30/1996 | CA2180319A1 Modified bacterial alkaline phosphatases and use thereof |
12/29/1996 | CA2180079A1 Use of balhimycin as production promoter in animals, and production promoter compositions |
12/29/1996 | CA2179439A1 Sucrose metabolism mutants |
12/27/1996 | WO1996041891A1 Process for identifying secretory genes from helicobacter pylori |
12/27/1996 | WO1996041876A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
12/27/1996 | EP0750042A1 Exopolysaccarides-producing lactic acid bacteria |
12/27/1996 | EP0750040A2 Macrophage stimulating protein variant and method for producing the same |
12/27/1996 | EP0749981A1 Monoclonal antibody |
12/27/1996 | EP0749952A1 Process for the preparation of citraconic anhydride |
12/27/1996 | EP0749496A1 Human dna mismatch repair proteins |
12/27/1996 | EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof |
12/27/1996 | EP0749490A1 EXPRESSION OF $i(BACILLUS THURINGIENSIS CRY) PROTEINS IN PLANT PLASTIDS |
12/27/1996 | EP0749489A1 Combined use of two expression cassettes for the production of a useful protein |
12/27/1996 | EP0749481A1 Humanized monoclonal antibodies against human interleukin-4 |
12/27/1996 | EP0749480A1 Novel forms of t cells costimulatory molecules and uses therefor |
12/27/1996 | EP0749479A1 Novel thiol protease inhibitor |
12/27/1996 | EP0749478A1 Yeast strains and modified albumins |
12/27/1996 | EP0749477A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
12/27/1996 | EP0749471A1 A process for the reduction of the nucleic acid content of a fungus imperfectus |
12/27/1996 | EP0749444A1 Hybrid human/animal factor viii |
12/27/1996 | EP0749441A1 Expression and purification of cloned human alpha-fetoprotein |
12/27/1996 | EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS |
12/27/1996 | EP0749320A1 Fibrin-specific antibody for use as an antithrombotic agent |
12/27/1996 | EP0749274A1 Fungicidal toxins from biocontrol bacteria |
12/27/1996 | EP0625190B1 New bacterium causing poultry disease and vaccine derived thereof |
12/27/1996 | EP0588841B1 Method for production of a whey protein hydrolyzate |
12/27/1996 | EP0332651B2 Method of isolating ca 125 antigen |
12/27/1996 | CA2224567A1 Process for identifying secretory genes from helicobacter pylori |
12/27/1996 | CA2221311A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
12/25/1996 | CN1138863A Chimeric proteins which block complement activation |
12/25/1996 | CN1138632A Expression and secretion of hereologous proteins by yarrowia lipolytica transformants |
12/25/1996 | CN1033651C Process for producing trans-L-hydroxyproline |
12/24/1996 | US5587462 Corticotropin releasing factor; stimulates the secretion and biosynthesis of acth |
12/24/1996 | US5587460 Controller of cell differentiation; immunology |
12/24/1996 | US5587319 Reacting racemic phosphinothricin with alpha-keto acid in presence of d-amino acid transaminase to form 3-carboxy-3-oxo-propylmethylphosphinate, then reacting with amino-group donor, catalyzed by l-amino acid transaminase |
12/24/1996 | US5587314 Intestine colonizing lactobacilli |
12/24/1996 | US5587307 FemA gene of staphylococcus epidermidis, femA protein, and vectors and microorganisms comprising the femA gene |
12/24/1996 | US5587304 Genetic engineering |
12/24/1996 | US5587302 T cell growth factor |
12/24/1996 | US5587299 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof |
12/24/1996 | US5587287 Thermostable polymerase specific antibody-containing DNA amplification composition and kit |
12/24/1996 | CA2028165C Selective fungal medium |
12/24/1996 | CA1338807C Plasmid vector with pectate lyase signal sequence |
12/21/1996 | CA2169201A1 Lactic bacteria producing exopolysaccharides |
12/19/1996 | WO1996040971A1 Method of transferring at least two saccharide units with a polyglycosyltransferase |
12/19/1996 | WO1996040968A1 Recombinant production of novel polyketides |
12/19/1996 | WO1996040967A1 Dehalogenation of polyamine, neutral curing wet strength resins |
12/19/1996 | WO1996040945A2 Nucleic acid respiratory syncytial virus vaccines |
12/19/1996 | WO1996040944A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
12/19/1996 | WO1996040943A1 Use of gram-positive bacteria to express recombinant proteins |
12/19/1996 | WO1996040937A2 Adenosine kinase polynucleotides |
12/19/1996 | WO1996040935A1 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
12/19/1996 | WO1996040934A1 Process for producing l-lysine |
12/19/1996 | WO1996040931A1 Neutralizing conformational epitopes of chicken anemia virus |
12/19/1996 | WO1996040923A1 Macrophage derived chemokine and chemokine analogs |
12/19/1996 | WO1996040918A2 Novel cd40l mutein |
12/19/1996 | WO1996040916A1 Icam-4 materials and methods |
12/19/1996 | WO1996040911A1 Modified steroid hormones for gene therapy and methods for their use |
12/19/1996 | WO1996040908A1 OLIGONUCLEOTIDES SPECIFIC FOR CYTOKINE SIGNAL TRANSDUCER gp130 mRNA |
12/19/1996 | WO1996040897A2 Chondroitinase i and chondroitinase ii producing mutants of p. vulgaris |
12/19/1996 | WO1996040880A1 Recombinant fowlpox viruses and uses thereof |
12/19/1996 | WO1996040877A1 Immortalization and disimmortalization of cells |
12/19/1996 | WO1996040867A1 Recombinant viral nucleic acids |
12/19/1996 | WO1996040865A1 Replacement therapy for dental caries |
12/19/1996 | WO1996040863A1 Conversion of compactin to pravastatin by actinomadura |
12/19/1996 | WO1996040788A1 Anti-allergy bispecific molecules |
12/19/1996 | WO1996040776A1 Methods for purifying authentic igf from yeast hosts |
12/19/1996 | WO1996040771A1 SINGLE CHAIN ANALOGS OF THE TGF-β SUPERFAMILY (MORPHONS) |
12/19/1996 | WO1996040766A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
12/19/1996 | WO1996040762A1 Monocyte chemotactic protein-4 |
12/19/1996 | WO1996040736A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
12/19/1996 | WO1996040722A1 Chromosomal expression of heterologous genes in bacterial cells |
12/19/1996 | WO1996040718A1 Expression of lipoproteins |
12/19/1996 | WO1996040714A1 GLYCINE AND PHASEOLUS α-D-GALACTOSIDASES |
12/19/1996 | WO1996040290A1 Immunological combination compositions and methods |
12/19/1996 | WO1996040284A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
12/19/1996 | WO1996040268A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
12/19/1996 | WO1996040260A2 Immunotoxins specific for cd80 and cd86 expressing cells |
12/19/1996 | WO1996040252A1 High affinity human monoclonal antibodies specific for rsv f-protein |
12/19/1996 | WO1996040246A1 Treatment of t cell mediated autoimmune disorders |